About BEPREVE
Quick and Comfortable Relief
BEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a prescription anti-allergy eye drop that relieves itching associated with allergic conjunctivitis. It works on the two primary components of the allergic process that can lead to the development of allergy symptoms in the eye.1
Clinical studies show that BEPREVE provides complete relief in about 3 minutes in the majority of eyes with even severe itching of the eyes.2 Clinical studies have also shown that BEPREVE provides continuing relief for up to 8 hours post dosing.1
The safety of BEPREVE was evaluated in a clinical study of 861 patients over a period of 6 weeks.1 BEPREVE was shown to be comfortable in the eye,3 and can be used in patients as young as 2 years of age.1
References: 1. BEPREVE [package insert]. Irvine, CA: ISTA Pharmaceuticals, Inc; 2010. 2. Clark JC, Williams JI, Gow JA, et al. Bepotastine besilate ophthalmic solution 1.5% rapidly eliminates ocular itching in more severely allergic subjects in the conjunctival allergen challenge model of allergic conjunctivitis. Poster presented at: Eastern Allergy Conference; May 6-9, 2010; Palm Beach, FL. 3. Data on file. ISTA Pharmaceuticals, Inc.
IMPORTANT SAFETY INFORMATION: BEPREVE is for topical ophthalmic use only. To minimize risk of contamination, do not touch the dropper tip to any surface. Keep the bottle closed when not in use. BEPREVE should not be used to treat contact lens–related irritation. Remove contact lenses prior to instillation of BEPREVE. The most common adverse reaction occurring in approximately 25% of patients was a mild taste following instillation. Other adverse reactions occurring in 2%-5% of patients were eye irritation, headache, and nasopharyngitis.

For Patients
For Health Care Professionals